David Marriott

Title: The Innovative Contributions of David Marriott

Introduction

David Marriott is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate chemokine receptor activity. His work is essential for advancing therapies for various diseases related to chemokine receptors.

Latest Patents

David Marriott holds a patent for "Substituted piperidine compounds useful as modulators of chemokine receptor activity." This invention provides compounds of a specific formula, detailing the processes for their preparation, pharmaceutical compositions containing them, and their therapeutic uses. The focus of this patent is on treating diseases and conditions related to chemokine receptor activity.

Career Highlights

David Marriott is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical industry. His expertise in chemistry and pharmacology has been instrumental in advancing new therapeutic options.

Collaborations

David has collaborated with notable colleagues, including Stephen Thom and Andrew Baxter. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

David Marriott's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the development of therapies for chemokine receptor-related diseases.